# Seasonal Trivalent Inactivated Split Virion Influenza Vaccine Clinical Trial (IVACFLU-S) - PHASE 2/3

> **NCT03095599** · PHASE2,PHASE3 · COMPLETED · sponsor: **Institute of Vaccines and Medical Biologicals, Vietnam** · enrollment: 889 (actual)

## Conditions studied

- Influenza, Human

## Interventions

- **BIOLOGICAL:** IVACFLU-S
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03095599
- **Lead sponsor:** Institute of Vaccines and Medical Biologicals, Vietnam
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-20
- **Primary completion:** 2017-10-05
- **Final completion:** 2017-10-05
- **Target enrollment:** 889 (ACTUAL)
- **Last updated:** 2019-07-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03095599

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03095599, "Seasonal Trivalent Inactivated Split Virion Influenza Vaccine Clinical Trial (IVACFLU-S) - PHASE 2/3". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03095599. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*